NexPoint Life Sciences III DST
NexPoint Life Sciences III DST is a real estate fund based in Dallas, Texas. According to its most recent Form D, filed Aug 11, 2026, it has sold $27,965,695 of interests to 92 investors since its first sale in Jan 2024. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include NREA LS III Contributor, LLC; NREA LS III Manager, LLC; Brian Mitts.
- Total raised
- $27,965,695Cumulative sales reported on Form D
- Investors
- 92
- First sale
- Jan 25, 2024
- Minimum investment
- $100,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- NREA LS III Contributor, LLC; NREA LS III Manager, LLC; Brian Mitts
- Latest Form D
- Aug 11, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about NexPoint Life Sciences III DST
What is the minimum investment for NexPoint Life Sciences III DST?
According to its latest Form D, filed Aug 11, 2026, the minimum investment NexPoint Life Sciences III DST accepts from an outside investor is $100,000.
Who can invest in NexPoint Life Sciences III DST?
NexPoint Life Sciences III DST is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has NexPoint Life Sciences III DST raised?
NexPoint Life Sciences III DST reports $27,965,695 sold from 92 investors on its Form D filed Aug 11, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is NexPoint Life Sciences III DST based?
NexPoint Life Sciences III DST is based in Dallas, Texas.
When did NexPoint Life Sciences III DST launch?
NexPoint Life Sciences III DST reports its first sale in Jan 2024, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every real estate fund
Raised more than 94% of the 1,419 real estate funds based in Texas, and more than 90% of all 7,350 that report sales.